Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Hepatitis - B 2018 NICHD 1R01HD092527-01 Antiviral prophylaxis and infant vaccination to prevent perinatal hepatitis B infection JOURDAIN, GONZAGUE INSTITUTE OF RESEARCH AND DEVELOPMENT FR $453,073
Hepatitis - B 2018 NIAID 5R01AI123271-02 Development of an HTS Assay for Discovery of HBV cccDNA Inhibitors GUO, HAITAO INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $392,250
Hepatitis - B 2018 NIAID 5R01AI122669-03 Optimization of alpha-hydroxytropolones as novel inhibitors of the HBV RNaseH TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $440,118
Hepatitis - B 2018 NIAID 5R01AI114748-04 miRNA-mediated premature T cell aging in vaccine failure during viral infection YAO, ZHI EAST TENNESSEE STATE UNIVERSITY TN $365,000
Hepatitis - B 2018 NIAID 5U19AI118608-02 7025 Newborn cohorts to discover and validate biomarkers of neonatal vaccine immunogenicity LEVY, OFER BOSTON CHILDREN'S HOSPITAL MA $1,007,531
Hepatitis - B 2018 NIAID 5U19AI118608-02 7027 Proteomics Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity STEEN, HANNO BOSTON CHILDREN'S HOSPITAL MA $835,849
Hepatitis - B 2018 NIAID 5U19AI118608-02 7028 Innovative OMIC integration to predict immunogenicity TEBBUTT, SCOTT UNIVERSITY OF BRITISH COLUMBIA CANADA $100,597
Hepatitis - B 2018 NIAID 5U19AI118608-02 7029 Immune status as a predictor of neonatal vaccine immunogenicity KOLLMANN, TOBIAS UNIVERSITY OF BRITISH COLUMBIA CANADA $100,575
Hepatitis - B 2018 NIAID 5U19AI118608-02 7030 In vitro modeling to characterize mechanisms of neonatal vaccine induced immune responses LEVY, OFER BOSTON CHILDREN'S HOSPITAL MA $164,146
Hepatitis - B 2018 NIAID 5R21AI124672-02 Defining approaches for improving HID and HPD compounds as HBV RNaseH antagonists TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $189,375
Hepatitis - B 2018 NIAID 5R01AI065256-08 HIV Antiretroviral Therapy and Hepatic Injury SHERMAN, KENNETH UNIVERSITY OF CINCINNATI OH $500,044
Hepatitis - B 2018 NIAID 5R01AI124006-03 Highly Attenuated Vesiculovirus-based Vectors as HBV Therapeutic Vaccines ROBEK, MICHAEL ALBANY MEDICAL COLLEGE NY $399,750
Hepatitis - B 2018 NIAID 5R01AI113923-04 Positive Immune-regulators During Chronic Viral Infections ZUNIGA, ELINA UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $459,066
Hepatitis - B 2018 NIAID 5R01AI114630-04 Innate Immune Response to Hepatocyte Death CRISPE, IAN UNIVERSITY OF WASHINGTON WA $521,263
Hepatitis - B 2018 NIAID 5R01AI110762-03 Molecular Mechanisms of HBV cccDNA Formation GUO, HAITAO INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $393,750
Hepatitis - B 2018 NIAID 5R01AI118933-03 Multimode Observation of Virus Capsid Assembly ZLOTNICK, ADAM INDIANA UNIVERSITY BLOOMINGTON IN $382,886
Hepatitis - B 2018 NIAID 5R01AI116639-04 Hepatitis B virus vaccine escape mutants TONG, SHUPING RHODE ISLAND HOSPITAL RI $362,250
Hepatitis - B 2018 NIAID 1R01AI134818-01 The Role of HBeAg in HBV Persistence GUO, HAITAO INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $418,840
Hepatitis - B 2018 NCI 5R01CA168912-05 Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines HE, YUKAI AUGUSTA UNIVERSITY GA $320,588
Hepatitis - B 2018 NIDDK 5K08DK101754-05 New Hepatocyte Model Systems to study Hepatitis B Virus Infection SCHWARTZ, ROBERT WEILL MEDICAL COLL OF CORNELL UNIV NY $159,508
Hepatitis - B 2018 NIDA 5R01DA025885-10 Sustainable HIV Risk Reduction Strategies for CJ Systems LEHMAN, WAYNE TEXAS CHRISTIAN UNIVERSITY TX $552,720
Hepatitis - B 2018 NIAID 1R01AI130022-01A1 Hepatitis B virus cccDNA SEEGER, CHRISTOPH RESEARCH INST OF FOX CHASE CAN CTR PA $457,500
Hepatitis - B 2018 NIDDK 5F31DK112607-02 A critical role for group 3 innate lymphocytes in hepatitis B virus pathogenesis JESPERSEN, JILLIAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $38,882
Hepatitis - B 2018 NIAID 1R21AI130745-01A1 Heterogeneity in Virus Capsid Assembly and Structure ZUCKERMAN, DANIEL OREGON HEALTH & SCIENCE UNIVERSITY OR $244,781
Hepatitis - B 2018 NIAID 1R21AI130815-01A1 Oligonucleotides for Targeted Viral Capsid Protein Destruction DEITERS, ALEXANDER UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $228,843
Hepatitis - B 2018 NIAID 1R03AI131066-01A1 Spatial and temporal profiling to unravel the host cell responses to hepatitis B virus infection POCHET, NATHALIE BRIGHAM AND WOMEN'S HOSPITAL MA $91,290
Hepatitis - B 2018 NIAID 5R01AI116269-04 Immune correlates of acute HBV recovery with and without HIV THIO, CHLOE JOHNS HOPKINS UNIVERSITY MD $616,491
Hepatitis - B 2018 NIAID 2R44AI124933-03 Development of a kit for the targeted depletion of abundant sequencesfromDNA/RNA libraries CARPENTER, MEREDITH ARC BIO, LLC MA $998,921
Hepatitis - B 2018 NIDDK 5R01DK044533-20 Mechanisms of Hepatocyte Transformation by the Hepatitis B Virus X Protein ANDRISANI, OURANIA PURDUE UNIVERSITY IN $346,173
Hepatitis - B 2018 NIAID 5R01AI125401-03 Developmental regulation of HBV biosynthesis by FoxA and DNA methylation MCLACHLAN, ALAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $399,750
Hepatitis - B 2018 NIDA 5R01DA040811-03 A Natural History Study of Buprenorphine Diversion, Self-Treatment, and Use of Drug Abuse Treatment Services DANIULAITYTE, RAMINTA WRIGHT STATE UNIVERSITY OH $581,500
Hepatitis - B 2018 NIGMS 5SC1GM111158-04 Biological Studies of alpha-Hydroxytropolones MURELLI, RYAN BROOKLYN COLLEGE NY $392,500
Hepatitis - B 2018 NCI 5UG3CA211551-02 Field-deployable platform for prognostic hepatic cancer screening in low-resource settings PORTER, MARC UNIVERSITY OF UTAH UT $403,427
Hepatitis - B 2018 NCI 5R21CA209940-02 Integrative genomic framework for dissecting regulatory mechanisms underlying hepatocellular carcinoma POCHET, NATHALIE BRIGHAM AND WOMEN'S HOSPITAL MA $175,001
Hepatitis - B 2018 NIAID 5R01AI121315-04 Taking aim at HBV eradication using novel NRTIs and Capsid effectors SARAFIANOS, STEFAN EMORY UNIVERSITY GA $590,494
Hepatitis - B 2018 FIC 5D43TW009771-05 HIV Co-infections in Uganda: TB, Cryptococcus, and Viral Hepatitis. MANABE, YUKARI JOHNS HOPKINS UNIVERSITY MD $292,517
Hepatitis - B 2018 NCI 2P01CA022443-41 8184 Project 2 - Mechanisms of Hepatitis B Virus Replication LOEB, DANIEL UNIVERSITY OF WISCONSIN-MADISON WI $387,645
Hepatitis - B 2018 NCI 2P01CA022443-41 8190 Core C - Virus Core JOHANNSEN, ERIC UNIVERSITY OF WISCONSIN-MADISON WI $76,647
Hepatitis - B 2018 NIAID 5R01AI113267-06 Evaluation of therapeutic benefits of HBV nucleocapsid assembly inhibitors GUO, JU-TAO BARUCH S. BLUMBERG INSTITUTE PA $537,218
Hepatitis - B 2018 NCI 5R01CA206465-03 (PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer JUSTICE, AMY YALE UNIVERSITY CT $512,833
Hepatitis - B 2018 NIAID 5R01AI132833-02 HBV Capsid Effectors SCHINAZI, RAYMOND EMORY UNIVERSITY GA $543,503
Hepatitis - B 2018 NIDDK 1R03DK117252-01 Identification of Hepatitis B Virus permissiveness factors SCHWARTZ, ROBERT WEILL MEDICAL COLL OF CORNELL UNIV NY $127,125
Hepatitis - B 2018 NIAID 5R01AI129540-02 Hepatitis B virus e antigen in viral persistence OU, J.-H. JAMES UNIVERSITY OF SOUTHERN CALIFORNIA CA $412,500
Hepatitis - B 2018 NCI 5R01CA188506-04 Dissection of Pten-regulated signals in hepatopathogenesis FENG, GEN-SHENG UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $404,404
Hepatitis - B 2018 NCI 5R01CA196692-04 Does Screening for HCC in Cirrhotic Patients Reduce HCC-related Mortality? IOANNOU, GEORGE SEATTLE INST FOR BIOMEDICAL/CLINICAL RES WA $273,336
Hepatitis - B 2018 NIDDK 5U01DK082872-11 Hepatitis B Research Network Clinical Centers LEE, WILLIAM UT SOUTHWESTERN MEDICAL CENTER TX $247,130
Hepatitis - B 2018 NIDDK 5U01DK082919-11 Harvard Hepatitis B Consortium LAU, DARYL BETH ISRAEL DEACONESS MEDICAL CENTER MA $396,375
Hepatitis - B 2018 NIAID 5R01AI125350-02 Mechanisms of HBV-Induced Innate Immunity SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $387,500
Hepatitis - B 2018 NIDDK 5U01DK082867-11 North Carolina Hepatitis B Research Network FRIED, MICHAEL UNIV OF NORTH CAROLINA CHAPEL HILL NC $262,153
Hepatitis - B 2018 NIDDK 5U01DK082923-11 Hepatitis B Clinical Research Network STERLING, RICHARD VIRGINIA COMMONWEALTH UNIVERSITY VA $276,570
Hepatitis - B 2018 NIAID 5F31AI134100-02 Engineered circular RNAs: A novel platform for genetically encoded RNA-based biosensors and their application as real-time viral infection reporters LITKE, JACOB WEILL MEDICAL COLL OF CORNELL UNIV NY $44,524
Hepatitis - B 2018 NIDDK 5U01DK082864-11 Hepatitis B Research Network - Data Coordination Center BELLE, STEVEN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $2,822,874
Hepatitis - B 2018 NIDDK 5U01DK082871-11 Midwest Hepatitis B Consortium DI BISCEGLIE, ADRIAN SAINT LOUIS UNIVERSITY MO $357,547
Hepatitis - B 2018 NIDDK 5U01DK082944-11 Hepatitis B Research Network (HBRN): Natural History and Treatment Studies TERRAULT, NORAH UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $1,361,363
Hepatitis - B 2018 NIAID 1R21AI138143-01 Consequences of HBV modulation of metabolic homeostasis in human hepatocytes BOUCHARD, MICHAEL DREXEL UNIVERSITY PA $232,127
Hepatitis - B 2018 NCI 5U01AI069924-13 International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA) EGGER, MATTHIAS UNIVERSITAT BERN SWITZE $298,960
Hepatitis - B 2018 NIAID 5U01AI069924-13 International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA) EGGER, MATTHIAS UNIVERSITAT BERN SWITZE $1,807,628
Hepatitis - B 2018 NICHD 5U01AI069924-13 International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA) EGGER, MATTHIAS UNIVERSITAT BERN SWITZE $325,000
Hepatitis - B 2018 NIDA 5U01AI069924-13 International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA) EGGER, MATTHIAS UNIVERSITAT BERN SWITZE $100,000
Hepatitis - B 2018 NCI 5U01AI069919-13 IeDEA West Africa Renewal 3 DABIS, FRANCOIS ADERA FR $225,000
Hepatitis - B 2018 NIAID 5U01AI069919-13 IeDEA West Africa Renewal 3 DABIS, FRANCOIS ADERA FR $273,992
Hepatitis - B 2018 NICHD 5U01AI069919-13 IeDEA West Africa Renewal 3 DABIS, FRANCOIS ADERA FR $250,000
Hepatitis - B 2018 NCI 1R21CA228089-01 Etheno Adducts in Liver Cancer PFEIFER, GERD VAN ANDEL RESEARCH INSTITUTE MI $247,950
Hepatitis - B 2018 NIAID 1R21AI135849-01A1 Defining the biology and public health risk of HBV Genotype E UPRICHARD, SUSAN LOYOLA UNIVERSITY CHICAGO IL $227,375
Hepatitis - B 2018 NIDDK 5U01DK082863-11 Hepatitis B Clinical Research Network Clinical Center: Michigan - Hawaii Consortium LOK, ANNA UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $241,832
Hepatitis - B 2018 NICHD 5R01HD085862-03 Impact of HIV PMTCT Interventions on HIV/HBV Co-infected Women and Their Infants BHATTACHARYA, DEBIKA UNIVERSITY OF CALIFORNIA LOS ANGELES CA $412,630
Hepatitis - B 2018 NIDDK 5U01DK082916-11 Immunologic and Virologic Correlates of the Age-Related Decrease in HBV DNA in Children SCHWARZ, KATHLEEN JOHNS HOPKINS UNIVERSITY MD $457,153
Hepatitis - B 2018 NIAID 1R21AI133632-01A1 Creation of a chronic HBV infection model in rhesus macaques BURWITZ, BENJAMIN OREGON HEALTH & SCIENCE UNIVERSITY OR $218,750
Hepatitis - B 2018 NIAID 5R44AI132034-02 Development of two simple and robust point-of-care assays for detection and therapy monitoring of hepatitis B in resource-limited settings LEE, HELEN DIAGNOSTICS FOR THE REAL WORLD, LTD CA $390,846
Hepatitis - B 2018 NIDDK 5U01DK082874-10 Observation Study of Persons with Chronic Hepatitis B Virus infection in North America JANSSEN, HARRY UNIVERSITY HEALTH NETWORK CANADA $577,003
Hepatitis - B 2018 NIAID 5R01AI127670-03 Regulation of Hepatitis B Virus Capsid Assembly HU, JIANMING PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $385,921
Hepatitis - B 2018 NIAID 5U19AI128910-02 7049 Administrative Core: Core A HADDAD, ELIAS DREXEL UNIVERSITY PA $77,441
Hepatitis - B 2018 NIAID 5U19AI128910-02 7050 Clinical Core: Core B KALEEBU, PONTIANO UGANDA VIRUS RESEARCH INSTITUTE UGANDA $160,000
Hepatitis - B 2018 NIAID 5U19AI128910-02 7055 Investigating the impact of helminth infection on microbioma composition and innate immunity generated during HepB vaccination. SEKALY, RAFICK- CASE WESTERN RESERVE UNIVERSITY OH $789,910
Hepatitis - B 2018 NIDDK 5R01DK103735-03 Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B COOPER, STEWART CALIFORNIA PACIFIC MED CTR RES INSTITUTE CA $707,841
Hepatitis - B 2018 NIDA 5UG3DA044830-02 Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE) FRIEDMANN, PETER BAYSTATE MEDICAL CENTER MA $548,410
Hepatitis - B 2018 NIDA 5UG3DA044829-02 Ending transmission of HIV, HCV, and STDs and overdose in rural communities of people who inject drugs (ETHIC) PHO, MAI UNIVERSITY OF CHICAGO IL $542,423
Hepatitis - B 2018 FIC 5U54CA221205-02 6392 Administrative Core HOU, LIFANG NORTHWESTERN UNIVERSITY AT CHICAGO IL $11,961
Hepatitis - B 2018 NCI 5U54CA221205-02 6392 Administrative Core HOU, LIFANG NORTHWESTERN UNIVERSITY AT CHICAGO IL $81,881
Hepatitis - B 2018 FIC 5U54CA221205-02 6394 Biomedical Informatics and Statistics Core LIU, LEI NORTHWESTERN UNIVERSITY AT CHICAGO IL $16,216
Hepatitis - B 2018 NCI 5U54CA221205-02 6394 Biomedical Informatics and Statistics Core LIU, LEI NORTHWESTERN UNIVERSITY AT CHICAGO IL $111,008
Hepatitis - B 2018 FIC 5U54CA221205-02 6395 Epigenetic Biomarkers of HIV-Associated Hepatocellular Carcinoma in Nigeria ROBERTS, LEWIS NORTHWESTERN UNIVERSITY AT CHICAGO IL $27,006
Hepatitis - B 2018 NCI 5U54CA221205-02 6395 Epigenetic Biomarkers of HIV-Associated Hepatocellular Carcinoma in Nigeria ROBERTS, LEWIS NORTHWESTERN UNIVERSITY AT CHICAGO IL $184,866
Hepatitis - B 2018 NIDDK 1R43DK113858-01A1 Enhancing Immunogenicity of VLV-Based Vaccines for Treatment of Chronic HBV NAKAAR, VALERIAN CAROGEN CORPORATION CT $224,710
Hepatitis - B 2018 OD 5K01OD024877-02 Combined Hepatitis B and HIV-1 envelope vaccination to augment T cell help via linked recognition of unrelated antigens POLLARA, JUSTIN DUKE UNIVERSITY NC $346,922
Hepatitis - B 2018 FIC 5U54CA190165-05 7861 The Role of HIV Infection in the Etiology and Clinical Manifestations of Hep Carcinoma KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $11,941
Hepatitis - B 2018 NCI 5U54CA190165-05 7861 The Role of HIV Infection in the Etiology and Clinical Manifestations of Hep Carcinoma KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $206,457
Hepatitis - B 2018 FIC 5U54CA190165-05 7862 Pre Malignant Cirrhosis and Hepatocellular Carcinoma in HIV Infected Ugandans KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $14,839
Hepatitis - B 2018 NCI 5U54CA190165-05 7862 Pre Malignant Cirrhosis and Hepatocellular Carcinoma in HIV Infected Ugandans KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $256,559
Hepatitis - B 2018 FIC 5U54CA190165-05 7863 Biomarker and Analytical Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $8,906
Hepatitis - B 2018 NCI 5U54CA190165-05 7863 Biomarker and Analytical Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $153,975
Hepatitis - B 2018 NIAID 1R01AI139762-01 Identifying and modulating therapeutic targets in a model of hepatitis B BARON, JODY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $566,743
Hepatitis - B 2018 NIAAA 1K01AA026864-01 Ethanol suppresses HBV peptide-MHC Class I presentation on hepatocytes GANESAN, MURALI UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $136,710
Hepatitis - B 2018 NIGMS 1R01GM129354-01 Single-Particle Analysis of Virus Capsid Assembly and Disassembly by Resistive-Pulse Sensing JACOBSON, STEPHEN INDIANA UNIVERSITY BLOOMINGTON IN $323,475
Hepatitis - B 2018 NICHD 1R03HD096131-01 Kidney Tubular Dysfunction in Hepatitis B Mono-Infected Women Receiving a Short Tenofovir Disoproxil Fumarate Course in Pregnancy and Postpartum Period to Prevent Mother to Child Transmission JOURDAIN, GONZAGUE INSTITUTE OF RESEARCH AND DEVELOPMENT FR $53,730
Hepatitis - B 2018 NIGMS 2R01GM108021-11A1 Computational modeling of viral capsid and bacterial microcompartment assembly HAGAN, MICHAEL BRANDEIS UNIVERSITY MA $322,525
Hepatitis - B 2018 NIDA 3R01DA025885-10S1 Sustainable HIV Risk Reduction Strategies for CJ Systems LEHMAN, WAYNE TEXAS CHRISTIAN UNIVERSITY TX $78,173
Hepatitis - B 2018 NIAID 1R21AI140499-01 Myeloid cell IFNGR regulation in persistent viral and secondary bacterial infections LENZ, LAUREL UNIVERSITY OF COLORADO DENVER CO $229,828
Hepatitis - B 2018 NIAID 3R13AI071925-08S1 Liver Disease and HIV SHERMAN, KENNETH UNIVERSITY OF CINCINNATI OH $25,000
Hepatitis - B 2018 NIAID 1R13AI140637-01 2018 International Meeting on the Molecular Biology of Hepatitis B Viruses BOUCHARD, MICHAEL HEPATITIS B FOUNDATION PA $6,000
Hepatitis - B 2018 NIAID 1R21AI138598-01A1 Telomere loss and T cell aging in HBV vaccine response in HIV-infected individual YAO, ZHI EAST TENNESSEE STATE UNIVERSITY TN $222,000
Hepatitis - B 2018 NIAID 1R01AI138810-01A1 Characterization of silently HBV-infected hepatocytes in HIV co-infection BALAGOPAL, ASHWIN JOHNS HOPKINS UNIVERSITY MD $790,717
Hepatitis - B 2018 NIAID 5U19AI111825-05 7689 Effects of Persistent Innate Immune Activation on Vaccine Efficacy RICE, CHARLES ROCKEFELLER UNIVERSITY NY $541,028
Hepatitis - B 2018 NCI 1U54CA221705-01A1 6118 Long-Term Adherence to Monitoring/Treatment in Underserved Asian Americans with Chronic HBV MA, GRACE TEMPLE UNIV OF THE COMMONWEALTH PA $248,885
Hepatitis - B 2018 NCI 1U54CA221705-01A1 6124 Community Outreach Core TAN, YIN TEMPLE UNIV OF THE COMMONWEALTH PA $195,975
Hepatitis - B 2018 NCI 1U54CA221704-01A1 6147 Full Research Project 1Long-Term Adherence to Monitoring/Treatment in Underserved Asian Americans with Chronic HBV GOLUB, SARIT HUNTER COLLEGE NY $116,530
Hepatitis - B 2018 NCI 1U54CA221704-01A1 6153 Community Outreach Core YEH, MING-CHIN HUNTER COLLEGE NY $103,584
Hepatitis - B 2018 NIAID 1R01AI141391-01 Adaptive Liver Tolerance via LSECs CRISPE, IAN UNIVERSITY OF WASHINGTON WA $388,750
Hepatitis - B 2018 NIA 5U19AI057229-15 7617 The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination DAVIS, MARK STANFORD UNIVERSITY CA $91,295
Hepatitis - B 2018 NIAID 5U19AI057229-15 7617 The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination DAVIS, MARK STANFORD UNIVERSITY CA $1,030,798
Hepatitis - B 2018 NIAID 7R21AI128325-03 Role of stem cell-derived T lymphocytes in chronic HBV infection SONG, JIANXUN TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR TX $185,625
Hepatitis - B 2018 NIAID 2R01AI043453-21 Mechanisms of Hepadnavirus Assembly and Replication HU, JIANMING PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $373,437
Hepatitis - B 2018 NIGMS 3R01GM104135-04S1 Post-transcriptional Gene Regulation by Cytoplasmic Poly (ADP-ribose) - Supplement for Equipment LEUNG, ANTHONY JOHNS HOPKINS UNIVERSITY MD $62,410
Hepatitis - B 2018 NIDA 3UG3DA044830-01S1 Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE) FRIEDMANN, PETER BAYSTATE MEDICAL CENTER MA $8,467
Hepatitis - B 2018 NIAID 1R01AI138797-01A1 Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infection SU, LISHAN UNIV OF NORTH CAROLINA CHAPEL HILL NC $797,362
Hepatitis - B 2018 NIAID 1R56AI139234-01 Epitranscriptomic regulation of HBV gene expression SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $392,500
Hepatitis - B 2018 NIDA 3R01DA025885-10S2 Sustainable HIV Risk Reduction Strategies for CJ Systems - Opioid Administrative Supplement LEHMAN, WAYNE TEXAS CHRISTIAN UNIVERSITY TX $139,241
Hepatitis - B 2018 NIAID 4R44AI129232-02 A Cytomegalovirus-based therapeutic vaccine for chronic hepatitis B BRUENING, ERIC TOMEGAVAX, INC. OR $685,089
Hepatitis - B 2018 OD 3U01DK082919-11S1 Harvard Hepatitis B Consortium LAU, DARYL BETH ISRAEL DEACONESS MEDICAL CENTER MA $127,225
Hepatitis - B 2018 NIDA 3UG3DA044830-02S1 Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE) FRIEDMANN, PETER BAYSTATE MEDICAL CENTER MA $359,907
Hepatitis - B 2018 NCI 1ZIACP005782-24 Epidemiology of Oncogenic Viruses O'BRIEN, THOMAS NIH $411,650
Hepatitis - B 2018 NCI 1ZIACP010127-23 Etiologic Studies of Diet and Cancer FREEDMAN, NEAL NIH $276,819
Hepatitis - B 2018 NIAID 1ZIAAI001040-11 International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs QUINN, THOMAS NIH $1,428,469
Hepatitis - B 2018 NIDDK 1ZIADK054500-22 Molecular Mechanisms Of Hepatitis B Viral infection, Pathogenesis And Persistence LIANG, T. JAKE NIH $1,569,787
Hepatitis - B 2018 NIDDK 1ZIADK054505-22 Mechanisms of Therapy and Model Development in Viral Hepatitis and Liver Diseases LIANG, T. JAKE NIH $897,021
Hepatitis - B 2018 NCI 3R44CA165314-04S1 A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC) LU, XUANYONG IMCARE BIOTECH PA $1,400
Hepatitis - B 2018 NIDDK 1ZIADK054509-21 Immunology of Acute and Chronic Viral Hepatitis REHERMANN, BARBARA NIH $875,252
Hepatitis - B 2018 NIDDK 1ZIADK054517-12 Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis B GHANY, MARC NIH $626,347
Hepatitis - B 2018 NCI 1ZIABC005793-24 Mechanism of viral hepatitis-mediated hepatocarcinogenesis WANG, XIN NIH $119,011
Hepatitis - B 2018 NCI 1ZIABC010297-21 Identification of Genetic Factors Associated with Infectious Diseases WINKLER, CHERYL NIH $355,272
Hepatitis - B 2018 NCI 1ZIABC010494-16 Small molecule targeting viral nucleotidyltransferases LE GRICE, STUART NIH $770,031
Hepatitis - B 2018 NCI 1ZIABC011486-06 Development of Novel Agents Active against Hepatitis B Virus MITSUYA, HIROAKI NIH $401,884
Hepatitis - B 2018 NCI 1ZIABC011824-01 Structural studies with regulatory RNAs LE GRICE, STUART NIH $385,016
Hepatitis - B 2018 NIAMS 1ZIAAR027002-40 Structural Biology Of Virus Assembly STEVEN, ALASDAIR NIH $1,493,212
Hepatitis - B 2018 NIAID 1ZIAAI000999-12 Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases FARCI, PATRIZIA NIH $1,662,693
Hepatitis - B 2018 NIAID 272201700041I-0-27200010-1 Task A21: Human Hepatitis B virus (HBV) mouse models for testing HBV therapeutics NO PI IDENTIFIED UTAH STATE UNIVERSITY UT $174,249


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer